Brain activity during rest is characterized by slow (0.01-0.1 Hz) fluctuations of blood oxygenation level-dependent functional magnetic resonance imaging signals. These fluctuations are organized as functional connectivity networks called resting-state networks, anatomically corresponding to specific neuronal circuits. As Parkinson's disease is mainly characterized by a dysfunction of the sensorimotor pathways, which can be influenced by levodopa administration, the present study investigated the functional connectivity changes within the sensorimotor resting-state network in drug-naïve patients with Parkinson's disease after acute levodopa administration. Using a double-blind placebo-controlled design, resting-state functional magnetic resonance imaging was carried out in 20 drug-naïve patients with Parkinson's disease, immediately before and 60 min after, oral administration of either levodopa or placebo. Control resting-state functional magnetic resonance imaging data were recorded in 18 age-and sex-matched healthy volunteers. Independent component analysis was performed to extract resting-state network maps and associated time-course spectral features. At the anatomical level, levodopa enhanced the sensorimotor network functional connectivity in the supplementary motor area, a region where drug-naïve patients with Parkinson's disease exhibited reduced signal fluctuations compared with untreated patients. At the spectral frequency level, levodopa stimulated these fluctuations in a selective frequency band of the sensorimotor network. The reported effects induced by levodopa on sensorimotor network topological and spectral features confirm that the sensorimotor system is a target of acute levodopa administration in drug-naïve patients with Parkinson's disease. Moreover, while the regional changes in supplementary motor area reflect the functional improvement in motor function, the rhythm-specific modulation induced by the dopamine precursor discloses a novel aspect of pharmacological stimulation in Parkinson's disease, adding further insight to the comprehension of levodopa action.
Introduction
Resting-state functional MRI allows us to investigate the human brain activity 'in vivo' by recording the blood oxygen level-dependent fluctuations in the absence of sensory stimulation and without any cognitive or motor task (Biswal et al., 1995; Lowe et al., 1998) . In fact, these 'intrinsic' haemodynamic oscillations have led to the decomposition of the resting-state blood oxygen level-dependent activity into multiple spatially distributed functional connectivity networks, called resting-state networks (van de Ven et al., 2004; Damoiseaux et al., 2006; Mantini et al., 2007) , including the most studied, the default mode network (Greicius et al., 2003) , which is relevant for cognition (Buckner et al., 2008) , and the sensorimotor network (Biswal et al., 1995) , which is crucial for the execution of voluntary movements and functionally connects regions within the supplementary motor area and the primary motor cortex (Xiong et al., 1999) .
In patients with Parkinson's disease, functional cortical changes, as assessed by functional MRI, are thought to be secondary to a functional deafferentation, caused by degeneration of dopaminergic neurons of the nigrostriatal system, which results in disruption of basal ganglia-thalamocortical loops underlying the classical motor signs and symptoms of Parkinson's disease (Sabatini et al., 2000; Mattay et al., 2002) . These alterations can be partially or fully restored by levodopa administration (Haslinger et al., 2001; Buhmann et al., 2003) .
The present study was aimed at revealing levodopa-induced acute changes in the resting-state functional connectivity of the sensorimotor network in drug-naïve patients with Parkinson's disease compared with matched untreated patients and healthy volunteers. In particular, the purpose was to assess how acute levodopa administration would change the topological features of the sensorimotor network, whose constituent regions are typically hypoactivated (e.g. the supplementary motor area) or hyperactivated (e.g. the premotor and primary motor cortices and cerebellum) during motor tasks (Playford et al., 1992; Jahanshahi et al., 1995; Rascol et al., 1997; Sabatini et al., 2000; Haslinger et al., 2001; Buhmann et al., 2003; Wu and Hallett, 2005) , and display a partially altered functional connectivity patterns at rest (Wu et al., 2009 (Wu et al., , 2011 , in patients with Parkinson's disease. In addition, given the mutual physical relationship between changes occurring in restricted neuronal networks and the global cortical dynamics, and the consequent interplay of the fast neuro-electrical oscillations with the functional MRI-detected slow haemodynamic oscillations (50.1 Hz) (Deco et al., 2011) , we further assessed whether levodopa would also modulate the spectral composition of sensorimotor network-specific resting-state functional MRI oscillations, thereby addressing a possible activation of an internal 'oscillator' of the motor system by pharmacological agents.
To achieve these aims, we used a double-blind placebocontrolled design and used a fully data-driven independent component analysis-based (McKeown et al., 1998; Hyvarinen et al., 2001) methodology to extract and characterize the resting-state functional connectivity of the sensorimotor network in terms of a whole-brain distributed map and time-course spectrum. To our knowledge, this is the first resting-state functional MRI study investigating the acute effects of a dopaminergic manipulation on the intrinsic sensorimotor network functional connectivity in drug-naïve patients with Parkinson's disease.
Materials and methods

Subjects and experimental design
The study was approved by the ethical committee of the Second University of Naples and all participants gave their written informed consent prior to their inclusion in the study in compliance with national legislation and the Code of Ethical Principles for Medical Research Involving Human Subjects of the World Medical Association (Declaration of Helsinki).
Twenty drug-naïve patients with Parkinson's disease (10 male, 10 female, age 64.75 AE 5.29 years) with a diagnosis of idiopathic Parkinson's disease according to the diagnostic criteria of the UK Parkinson's Disease Society Brain Bank (Gibb and Lees, 1988) were studied. Disease severity was assessed using the Hoehn and Yahr stages (Hoehn and Yahr, 1967) and the Unified Parkinson's Disease Rating Scale (Fahn, 1987) . Global cognitive function was assessed by means of Mini-Mental State Examination and Frontal Assessment Battery. None of the patients had been previously exposed to any prodopaminergic agents or was under treatment with anticholinergic agents, antidepressants or other centrally acting drugs. Moreover, they were not suffering from any other neurological or psychiatric disorder.
Ten drug-naïve patients with Parkinson's disease (five male, five female, mean age AE SD 60.80 AE 2.7) were assigned to the levodopa group and 10 patients (five male, five female, mean age AE SD 66.7 AE 1.67 years) to the placebo group. Demographic and clinical parameters of both patients' subgroups are summarized in Table 1 .
All patients of the levodopa group received an oral administration of immediate-release levodopa/carbidopa (250/25 mg, respectively), as commonly performed in the acute levodopa challenge test in the diagnosis of idiopathic Parkinson's disease (Clarke and Davies, 2000) . All patients were scanned twice in the same morning, immediately before ('OFF medication' condition) and 60 min after ('ON medication' condition) drug or placebo administration, consistent with the expected time peaks of plasma levodopa levels (Contin and Martinelli, 2010) . After each scanning session, motor performance was measured outside the scanner according to the Unified Parkinson's Disease Rating Scale (III) score by an experienced neurologist (A.T.) who was blinded to the patients' treatment status. To avoid possible systematic effects of circadian origin, all patients were scanned on the same week-day, with the two scans starting at the same day times of the morning.
We also scanned 18 healthy age-matched control subjects (Table 1) . Control subjects were only scanned once, without treatment, at morning day times, randomly, but uniformly, distributed between the time of the first and the second scan of the patients.
Magnetic resonance imaging
Magnetic resonance imaging was performed on a 3-T scanner (HDxt, General Electric Medical System) equipped with an eight-channel parallel head coil.
Each resting-state functional MRI scan consisted of 240 volumes of a repeated gradient-echo echo planar imaging sequence (repetition time = 1508 ms, number of axial slices = 29, matrix size = 64 Â 64, field of view = 256 mm, thickness = 4 mm, interslice gap = 0 mm). During the functional scan, subjects were asked to simply stay motionless, awake and relaxed with their eyes closed; no visual or auditory stimuli were presented at any time during functional scanning.
Three-dimensional T 1 -weighted images (fast spoiled gradient echo BRAVO sequence, voxel size = 0.9 Â 0.9 Â 1.2 mm 3 ) were acquired in the same session to have high-resolution spatial references for registration and normalization of the functional images.
In patients, the functional and anatomical series were repeated twice in the same morning as described in the previous paragraph. During each functional scan, the timing of physiological cycles were recorded by a pulse-oximeter placed on the left index finger and a pneumatic belt positioned at the level of the abdomen of the subjects. The cardiac and respiratory measurement devices were integrated into the MRI scanner and data were automatically synchronized to image acquisition. Physiological signals were displayed on the console and the digital samples (40 Hz) saved to text files.
Resting-state functional magnetic resonance imaging data preparation
Standard image data preparation, normalization and preprocessing and statistical analysis and visualization were performed with the BrainVoyager QX software (Brain Innovation B.V.) (Goebel et al., 2006) . Functional data preprocessing included the correction for slice scan timing acquisition, the 3D rigid body motion correction and the application of a temporal high-pass filter with cut-off set to three cycles per time course. Structural and functional data were co-registered and spatially normalized to the Talairach standard space using a 12-parameter affine transformation. In the course of this procedure, the functional images were resampled to an isometric 3-mm grid covering the entire Talairach box. To account for possible blood oxygen level-dependent effects due to cardiac pulsation and respiratory cycle (Birn et al., 2008) , physiological noise correction was performed on each functional scan using the RETROICOR technique (Glover et al., 2000) . Time courses for components of heart rate, respiration and respiration volume per time were created from the recorded physiological signals at the functional MRI sampling rate using Matlab scripts (The Mathworks) available from the AFNI suite (Cox, 1996) and used, together with the motion estimate time courses available from the previous 3D rigid body motion correction, as predictors in single-study general linear model analysis (Friston et al., 1995) of each functional scan. Using the residual time courses from this general linear model allowed us to regress out possible signal fluctuations time-locked with the phase of cardiac and respiratory cycles and residual movement-related signal fluctuations.
Resting-state functional magnetic resonance imaging data analysis
Single-subject and group-level independent component analyses were performed on the preprocessed functional time series and the estimated independent components using a plug-in extension of BrainVoyager QX implementing the fastICA algorithm (Hyvarinen, 1999) .
For each subject and each scan, 40 independent components were extracted and scaled to spatial z-scores (i.e. the number of standard deviations of their whole-brain spatial distribution). These values express the relative amount a given voxel is modulated by the activation of the component (McKeown et al., 1998) and hence reflect the amplitude of the correlated fluctuations within the corresponding functional connectivity network. The final number of independent components is a free parameter, which has previously been either empirically determined or estimated (Calhoun et al., 2009) as the number of principal components retained in the multivariate data. This number typically lies between 20 and 60 depending on the data. In the present work, we chose to keep a number of principal components corresponding to one-sixth of the number of time points (Greicius et al., 2007) and accounting for 499.9% of the total variance. To select a possible independent component of interest (i.e. an independent component associated with a given resting-state network, such as the sensorimotor network) in each subject and each scan, we used resting-state network spatial templates from a previous study based on the same methodology (Esposito et al., 2010) . These resting-state network templates consisted of inclusive binary masks obtained from the thresholded resting-state network group-level statistical maps of a separate population of untreated control subjects, and were used here to independently select the sensorimotor network components in all patient and control data sets of the present study. In more detail, the sensorimotor network template masks were applied to each single-subject independent component in such a way to select one best-fitting component for each patient and scan as the one with the highest goodness of fit values (goodness of fit = mean independent component value inside mask À mean independent component value outside mask) (Greicius et al., 2004; Greicius, 2008; Petrella et al., 2011) . To avoid independent component analysis sign ambiguity, each component sign was adjusted in such a way to have all goodness of fit positive valued.
Scan (time point)-and group-specific random-effects one-sample t-test maps were generated from the selected independent components to visualize the average sensorimotor network functional connectivity distribution separately for the control (n = 18) and drug-naïve patients with Parkinson's disease (n = 20) groups (both in the OFF state) and for the levodopa (n = 10) and placebo (n = 10) drug-naïve patients with Parkinson's disease subgroups (both in the OFF medication and in the ON medication states) (main effects). Random-effects two-sample t-test maps resulting from the between-subject comparisons of the sensorimotor network maps between the control and drug-naïve Parkinson's disease patient groups (in the ON medication state), and 'levodopa' and 'placebo' drug-naïve Parkinson's disease subgroups (in the ON medication state), as well as from the within-subject comparison of the sensorimotor network maps between the ON medication and OFF medication states in the levodopa group, were generated to detect regional differences in the sensorimotor network component distributions. In addition, to fully disentangle levodopa-specific regional effects, the selected individual independent component maps of drug-naïve patients with Parkinson's disease were also entered into a two-way ANOVA, with one within-subject 'fixed' factor with two levels ('scan 1' and 'scan 2') and one between-subject 'random' factor with two levels ('levodopa' and 'placebo' groups) and, from this model applied to each single voxel, an F-map of the 'scan by group' interaction was obtained. For all the above maps, statistically significant regional effects were only accepted for compact clusters surviving the joint application of a voxel-and a cluster-level threshold, which were chosen using a non-parametric randomization approach. Namely, an initial uncorrected threshold was applied (P = 0.01) to all voxels and, then, a minimum cluster size was calculated that protected against false-positive clusters at 5% after 500 Montecarlo simulations (Forman et al., 1995; Goebel et al., 2006) .
As the sensorimotor network mask did not include the basal ganglia, a region of interest-based analysis of the sensorimotor network functional connectivity was also performed in the basal ganglia and thalamus. Using the Harvard-Oxford subcortical structural atlas (Frazier et al., 2005; Desikan et al., 2006; Makris et al., 2006; Goldstein et al., 2007) distributed with the FMRIB Software Library (Smith et al., 2004; Woolrich et al., 2009; Jenkinson et al., 2012) , we anatomically subdivided the basal ganglia into caudate, putamen and pallidum (globus pallidus). Then, the average functional connectivity levels within the sensorimotor network distribution were calculated in each group and subgroup. The independent component analysis component scores were used in all statistical tests because at each voxel these reflect the amplitude of the signal fluctuations that are correlated within the specific functional connectivity network (the sensorimotor network in our case). Therefore, possible changes of this parameter, observed either at the level of single voxels (maps) or at the level of the regions of interest (after local averaging), indicate functional connectivity changes within the considered network. For anatomically defined regions of interest, only positive-valued independent component analysis component scores, representing positive within-network correlations, were selected for averaging.
Scan (time point)-and group-specific spectral power information were obtained from the sensorimotor network (and for control, from the default mode network and other typical resting-state networks, similarly selected with the appropriate template), using the time course of activity corresponding to the selected individual independent components. To this purpose, first, the independent component time-course spectra were obtained using the fast fourier transform function in Matlab (The Mathworks). Then, to avoid independent component analysis scale ambiguity, and before statistical pooling, the proportion of the total resting-state network spectral power to the canonical low-frequency range of spontaneous blood oxygen level-dependent fluctuations (0.01-0.1 Hz) was computed (Zuo et al., 2010) . In addition, following Zuo et al. (2010) , we further subdivided the relative contribution of each independent component time-course spectrum to the whole detectable frequency range into four separate bands: slow-5 (0.01-0.027 Hz), slow-4 (0.027-0.073 Hz), slow-3 (0.073-0.198 Hz) and slow-2 (0.198-0.25 Hz). We used the same terminology and separation of frequency bands introduced by Penttonen and Buzsá ki (2003) in neurophysiology and later applied in the study of slow functional MRI fluctuations by Di Martino et al. (2008) and Zuo et al., (2010) . In neurophysiology, this approach was originally inspired by the observation that behaviourally relevant brain oscillations have their centre frequencies distributed linearly, forming an arithmetic progression on the natural logarithmic scale (see also Penttonen and Buzsá ki, 2003; Buzsaki and Draguhn, 2004) . Following the same approach, Di Martino et al. (2008) extended the oscillation classes down to 'slow-6' (0.0052-0.010 Hz) (which was below our high-pass filter cut-off) and 'slow-5' (0.010-0.027 Hz).
The same two-sample t-tests and two-way ANOVA interaction model described above for the spatial analysis were also applied to selected spectral measures to assess the statistical significance of the effects of levodopa. For the two-sample t-tests in the canonical bands, as grey matter voxels's activity mainly contributes to the first two bands (Zuo et al., 2010; Baria et al., 2011) , the statistical tests were restricted to slow-5 and slow-4, thereby a factor of two was applied for multiple comparison correction. For the analysis performed within the band slow-5, a correction factor of seven was applied, as the total number of frequency bins was seven and all frequencies were considered independent and equally probable. No additional correction was needed for the two-way interaction analysis as this was restricted to a single band or frequency already exhibiting within-or between-group significant effects (P 5 0.05, corrected for multiple comparisons).
Results
When comparing the motor performance of the drug-naïve patients with Parkinson's disease before and after drug administration (immediately following the resting-state functional MRI scans), a statistically significant change was observed in the mean UPRDS III score for the levodopa group (P 5 0.05), but not for the placebo group (P 4 0.05) ( Fig. 1 and Table 1 ). Figure 2 reports the random-effects group-level t-maps for the sensorimotor network of control healthy volunteers and drug-naïve patients with Parkinson's disease groups in the OFF medication state, as main effects, as well as the random-effects group-level t-map for the difference between controls and drug-naïve patients with Parkinson's disease in the OFF medication state. Consistent with previous studies (Mantini et al., 2007; Esposito et al., 2010) , the sensorimotor network functional connectivity of the control group recruited, bilaterally, the primary and supplementary motor and the primary and secondary sensory cortices. On average, both sensorimotor network component maps obtained in healthy volunteers and untreated drug-naïve patients with Parkinson's disease recruited bilaterally the primary motor cortex and the supplementary motor area (Table 2) ; however, the subtraction of the sensorimotor network component maps of drug-naïve patients with Parkinson's disease from controls showed a positive and statistically significant regional difference only in the supplementary motor area (Table 3) . Figure 3 reports the random-effects group-level t-maps for both experimental time points (OFF medication and ON medication conditions) and drug-naïve Parkinson's disease subgroups (levodopa and placebo groups) as main effects. On average, the sensorimotor network component maps of all four experimental groups showed a recruitment of the primary motor cortex. However, an increase in the sensorimotor network functional connectivity was detected only in the supplementary motor area when comparing the drug-naïve Parkinson's disease group before and after levodopa treatment and the drug-naïve Parkinson's disease levodopa arm versus the drug-naïve Parkinson's disease placebo arm. No statistically significant difference was detected between the groups in the primary motor cortex. Figure 4 reports the random-effects group-level t-maps: (i) the differences in ON medication minus OFF medication conditions in the same patients ( Fig. 4A ); (ii) the differences in levodopa ON medication group minus placebo group (Fig. 4B) ; and (iii) the interaction between the levodopa and placebo groups, before and after treatment (Fig. 4C ). The subtraction of the sensorimotor network component maps within the levodopa group, in the ON medication and OFF medication conditions, showed a significant increase of functional connectivity in the caudal part of the cingulate cortex, encompassing the supplementary motor area. Similarly, the subtraction of the sensorimotor network component maps of the placebo from the levodopa group, after treatment, showed an increase of functional connectivity in the same area (Table 3) . Finally, the interaction analysis showed the most selective effect (Table 3) : an increase of functional connectivity at the line passing through the anterior commissure, which marks the border between supplementary motor area and pre-supplementary motor area (Nachev et al., 2008) . A region of interest-based analysis of the sensorimotor network component maps of the individual groups in this region clearly showed that the average functional connectivity level of the untreated drug-naïve Parkinson's disease groups was approximately half the level of healthy controls (or less) and that this level was normalized by levodopa in the treated drug-naïve Parkinson's disease group (Fig. 5) . Figure 6 reports the results of the region of interest analysis of the sensorimotor network functional connectivity in the basal ganglia and the thalamus. Considering only positive independent component analysis component scores accounting for the positive within-network correlations, levodopa significantly increased the participation of the right thalamus to the sensorimotor network (group Â scan interaction, P 5 0.05 corrected for multiple comparisons across all regions of interest). Descriptively (P 5 0.05, uncorrected), this analysis also suggested a levodopa-induced increase of sensorimotor network functional connectivity in all regions of interest except the pallidum. Particularly, in the thalamus and caudate regions of interest, levodopa increased the sensorimotor network connectivity to levels above those seen in healthy controls, even if there was no difference between the control group and the levodopa group in the OFF medication condition.
The sensorimotor network in levodopa-treated drug-naïve patients with Parkinson's disease exhibited a statistically significant increase in the amplitude of the correlated fluctuations within the canonical slow-5 band (P 5 0.05, corrected) ( Fig. 7 and Table 4 ), while this effect was not evident in the default mode network (Fig. 8 ). Within this band, the levodopa drug-naïve Parkinson's disease group in the OFF medication state, the placebo drug-naïve Parkinson's disease and the control groups were all characterized by one dominant spectral peak located between 0.015 and 0.020 Hz. In contrast, after levodopa administration, sensorimotor network oscillations significantly increased in the range between 0.020 and 0.030 Hz (P 5 0.05, corrected), with a second well-tuned rhythm appearing in this higher sub-band, whereas no significant changes were evident in the lower sub-band rhythm. This levodopa-specific sensorimotor network rhythm was not equally expressed in the sensorimotor network of the control group, or in the default mode network of all studied groups, that exhibited a less tuned profile and a more flat spectrum across the whole slow-5 band (Fig. 9) . Moreover, when considering the spectral features of the 'raw' resting-state functional MRI time courses of single sensorimotor network constituent regions, including the supplementary motor area, these also exhibited a flat spectrum in the slow-5 band (data not shown).
Beyond the default mode network, a similar rhythm-specific levodopa-induced modulation was not observed in other typical resting-state networks, including the visual and auditory networks, the fronto-parietal and superior-parietal networks and the so called 'self-referential' and 'salience' networks (for reference see Damoiseaux et al., 2006; Mantini et al., 2007; Esposito et al., 2010; Sadaghiani et al., 2010 Sadaghiani et al., , 2012 . In fact, apart from the sensorimotor network, the two-way group Â scan interaction was not statistically significant in any of these resting-state networks, and in both the slow-5 and slow-4 frequency bands (Table 5 ). It is noteworthy that even when the group comparisons yielded significant differences between the ON medication and OFF medication states or between the levodopa group in the ON medication state and the control group, none of these effects were statistically significant at the sensorimotor network frequency peak induced by levodopa in the slow-5 band.
Discussion
Resting-state functional MRI allows a robust task-independent fractionation of the spontaneous brain activity into multiple domain-specific neuroimaging patterns, linking the underlying neurophysiology and neuroanatomy (van den Heuvel et al., 2009; Brookes et al., 2011; Scholvinck et al., 2011) , and potentially addressing the pharmacological modulation of the intrinsic functional connectivity in several brain networks (Esposito et al., 2010; Khalili-Mahani et al., 2011) .
The present study was designed to explore the levodopainduced modulation of the resting-state sensorimotor network in drug-naïve patients with Parkinson's disease following an acute levodopa challenge test. To our knowledge, this is the first resting-state functional MRI study in drug-naïve patients with Parkinson's disease exploring both topological and spectral changes of the intrinsic sensorimotor network functional connectivity during acute levodopa administration, in a task-and regionindependent fashion. Our results demonstrate that acute levodopa administration significantly enhances the spontaneous sensorimotor network functional connectivity in drug-naïve patients with Parkinson's disease and that this enhancement is both regionally and spectrally selective. In fact, within the sensorimotor network component distribution and spectrum, the amplitude of the correlated blood oxygen level-dependent signals increased preferentially in the supplementary motor area region and in the slow-5 canonical band of low-frequency resting-state functional MRI fluctuations. Furthermore, we provide evidence that levodopa stimulates a specific low-frequency rhythm within slow-5.
Using different neuroimaging modalities, previous works have shown that the continuous neuronal activity measurable at rest has a complex spatial or spectro-temporal structure and that conventional brain activations (i.e. neuronal changes evoked by a perceptual or cognitive task) may be directly influenced by, or dependent, to some extent, on possible changes in this structure (Gusnard and Raichle, 2001; Eichele et al., 2008; Scholvinck et al., 2012) .
We found that acute levodopa administration increases sensorimotor network-specific resting-state functional MRI fluctuations in the supplementary motor area of drug-naïve patients with Parkinson's disease, a region where the same signals were found suppressed in untreated drug-naïve patients with Parkinson's disease, compared with healthy normal controls. These findings are in line with previous studies demonstrating how levodopa (or other dopamine-mimetic agents) can improve motor performance by increasing the task-evoked activity (Haslinger et al., 2001) or the functional connectivity pattern (Wu et al., 2009) in the supplementary motor area. Moreover, the fact that within the supplementary motor area, the levodopa effect is anatomically selective at the border of the supplementary motor area and the pre-supplementary motor area of drug-naïve patients with Parkinson's disease, rather than in the primary motor cortex, further confirms the crucial role played by this region in the pathogenesis of bradykinesia in Parkinson's disease, with the consequence that the functional improvement in motor performance usually seen after levodopa administration pertains principally to motor control (i.e. preparation and initiation of a movement), rather than to actual motor execution (Deiber et al., 1991; Playford et al., 1992; Jahanshahi et al., 1995; Jenkins et al., 2000; Tanji and Hoshi, 2001; Cunnington et al., 2002) . This is also consistent with previous resting-state functional MRI studies in Parkinson's disease (Wu et al., 2011) , which have shown similar results by defining a seed in the pre-supplementary motor area based on task activation and detected higher functional connectivity of the pre-supplementary motor area with the primary motor regions (Wu et al., 2011) . In contrast to previous works, however, our conclusion did not imply or require the choice of a specific motor task or defining the lay-out of the 'seeding' region(s) to detect the regional effects of levodopa administration and therefore pertains to the entire intrinsic distribution of the sensorimotor network functional connectivity of patients with Parkinson' s disease. This would also explain the apparent discrepancy with other previous resting-state functional MRI studies reporting both increased and decreased functional connectivity in the motor cortex of patients with Parkinson's disease (Helmich et al., 2010; Baudrexel et al., 2011) . However, in these studies, different seeds were used in distinct structures of the basal ganglia and the thalamus.
While the reported supplementary motor area findings of Parkinson's disease-related suppression and supplementary motor area levodopa-related restoration are consistent with several previous ('task-related') motor functional MRI studies, we did not detect any compensatory effects in other regions of the sensorimotor network, like primary motor cortex (Sabatini et al., 2000; Haslinger et al., 2001) . One possible explanation is that these compensatory mechanisms come into play only during task-related motor performances and not during rest.
To assess the functional role of the basal ganglia and the thalamus in the sensorimotor network, a separate region of interest analysis was performed using a standard anatomical definition of these subcortical structures. This analysis revealed that levodopa increased the participation of these subcortical structures in the sensorimotor network, mainly in the right thalamus. However, because a similar trend was also visible in the putamen, in the caudate and in the left thalamus, we cannot exclude a more generalized up-regulation of the thalamo-cortical functional connectivity of the motor network (Johansen-Berg et al., 2005) .
Previous resting-state functional MRI works have shown that, spectrally, the resting-state functional MRI activity is characterized by low-frequency components in the range 0.01-0.1 Hz, which can be further subdivided in multiple canonical sub-bands to better reflect the neural origin of their sources (Zou et al., 2008 (Zou et al., , 2010 . We found that acute levodopa effects on the sensorimotor network were all spectrally concentrated in the 'slow-5' canonical band, and we believe that this result was not influenced by confounds. In fact, in the present study, we took care of the possible confounds deriving from residual motion, respiratory or aliased cardiac signals by correcting each data set using standard procedures. Furthermore, these confounds have been shown to contribute to slow-2 and slow-3 frequency bands (Cordes et al., 2001) , whereas slow-4 and slow-5 oscillations primarily originate from the grey matter (Zuo et al., 2010) .
Intriguingly, within the slow-5 canonical band, we observed that the sensorimotor network-specific resting-state functional MRI oscillations of levodopa-treated drug-naïve patients with Parkinson's Sensorimotor changes in Parkinson's disease by levodopa Brain 2013: Page 9 of 16 | 9 by guest on October 7, 2016 http://brain.oxfordjournals.org/ disease were organized in two separate sub-bands, around two well-tuned spectral peaks. The first (lower-frequency) peak was common to all examined pharmacological states (ON and OFF) and drug-naïve Parkinson's disease groups (levodopa and placebo), as well as to the (untreated) control group, while the second (higher-frequency) peak was only seen in levodopa-treated drug-naïve patients with Parkinson's disease in the ON medication state. In other words, levodopa was found to stimulate or modulate a specific higher-frequency rhythm, while a lower-frequency rhythm remained unchanged with respect to untreated conditions. Based on this finding, we may speculate that either a new independent oscillatory process has been activated by levodopa or that levodopa modulates the sensorimotor network not on its main natural rhythm, but on a different rhythm representative of some exogenous oscillating activity. In both cases, the sensorimotor network spectral composition resulting from levodopa treatment is highly evocative of two different oscillating systems supporting the sensorimotor network functional connectivity, of which only one, tuned on the higher-frequency sub-band, is affected.
The well-tuned spectral composition visible for the sensorimotor network in the levodopa ON medication state was not evident in any of the single sensorimotor network regions (taken in isolation from the network), and in any of the other resting-state networks, including, for example, the default mode network; in contrast, both isolated sensorimotor network regions and the default mode network exhibited a substantially flat spectral composition within the canonical slow-5 band, and none of the other resting-state networks exhibited similar spectral changes at the sensorimotor network frequency peak induced by levodopa. This suggests that the reported evidence of multiple resting-state rhythms for the sensorimotor network, of which one is levodopa-independent and one levodopa-dependent, is specific to the whole sensorimotor network and is to be interpreted as a global effect of levodopa on the integrated sensorimotor system, rather than as an effect on one localized neural generator. While this evidence does not exclude that levodopa may have affected other functional domains, such as the cognitive or affective domain (Cools, 2011; Cools and D'Esposito, 2011) , causing spatial changes in other resting-state networks, the fact that this was unique to the sensorimotor network would probably explain why such a rhythm-specific levodopa-induced effect was not seen and reported in previous resting-state functional MRI levodopa studies, all of which were conducted with seed-based (and, therefore, region-dependent) correlation techniques, even when normal healthy subjects (drug-naïve with respect to levodopa) were studied (Kelly et al., 2009 ). On the other hand, a comprehensive investigation of other functional systems by a detailed spatial analysis of other resting-state networks goes beyond the scope of the present study. This is not the first study using spectral measures for characterizing resting-state blood oxygen level-dependent activity and functional connectivity in Parkinson's disease and the effect of levodopa on these resting-state functional MRI patterns.
In one study, for instance, by measuring the total amplitude of the low-frequency fluctuations in the full band 0.01-0.08 Hz, Skidmore et al. (2011) have found regions of both decreased and increased resting-state activity in patients with Parkinson's disease in comparison with normal control subjects. Among other regions, reduced low-frequency blood oxygen level-dependent activity was specifically detected in the supplementary motor area. However, because no spectral decomposition or functional Levodopa (ON medication, n = 10) 4 controls (n = 18) Slow-5 (0.01-0.027 Hz) 0.019 0.039 Levodopa (ON medication, n = 10) 4 levodopa (OFF medication, n = 10) Slow-5 (0.01-0.027 Hz) 0.0092 0.018 Levodopa (ON medication, n = 10) 4 placebo (ON medication, n = 10) Slow-5 (0.01-0.027 Hz) 0.040 0.080 Scan by group interaction (two-way ANOVA) Slow-5 (0.01-0.027 Hz) 0.044 not applied Levodopa group (ON medication, n = 10) 4 controls (n = 18) Slow-5 (peak) (0.020-0.025 Hz) 0.0033 0.023 Levodopa (ON medication, n = 10) 4 levodopa (OFF medication, n = 10) Slow-5 (peak) (0.020-0.025 Hz) 0.0046 0.033 Scan by group interaction (two-way ANOVA) Slow-5 (peak) (0.020-0.025 Hz) 0.019 not applied
Values in bold indicate statistically significant P-values (p50.05).
network analysis was performed, it is objectively difficult to relate our findings to this study. In apparent contradiction with our results, other studies (Kwak et al., 2010 (Kwak et al., , 2012 have reported that levodopa treatments reduce, rather than increase, the amplitude of low-frequency oscillations, thereby restoring the normal oscillations in an otherwise functionally hyperconnected resting brain. However, there are at least two methodological differences between this study and those by Kwak et al. (2010 Kwak et al. ( , 2012 potentially explaining the apparent discrepancy of the findings: first, Kwak and colleagues (2010) studied chronically treated mild to moderate stage patients with Parkinson's disease with a practical OFF medication approach, which is substantially different from the 'medication-free' status studied here. Second, both the seed-based functional connectivity analysis (Kwak et al., 2010) and the voxel-based spectral analysis (Kwak et al., 2010) were based on 'full variance' voxel-level time courses and not on independent component analysis component maps and time courses. Thereby, in the absence of a functional component separation, not only the functional connectivity pattern strictly depends on the chosen 'seeds', but the resulting spectral profiles may depend on all functional sources of variances contributing to the selected region or voxel. This aspect may be particularly relevant when different seeds can generate distinct but overlapping spatial networks with potentially different mechanisms of levodopa modulation (Kelly et al., 2009; Helmich et al., 2010; Baudrexel et al., 2011) .
It should be also noted that, unlike the supplementary motor area spatial findings, the reported spectral effects of levodopa in the sensorimotor network did not reflect a normalization of the functional connectivity. Indeed, both drug-naïve Parkinson's disease groups in the OFF medication state were not different from controls in their sensorimotor network spectral power distributions. Thus, it is conceivable that the rhythm-specific modulation observed in the drug-naïve Parkinson's disease group in the ON medication state was independent of the striatal dopamine levels. In this case, controls studied in an ON medication state would likely show the same effect. Alternatively, we may hypothesize that the normalization of the supplementary motor area functional connectivity caused by acute levodopa administration makes some dopamine-dependent oscillations manifest in the upper slow-5 band (0.02-0.03 Hz), which would be otherwise latent in early disease stage drug-naïve patients with Parkinson's disease without treatment. In this case, our findings would point to a pathological oscillatory condition similar to that reported by Kwak 2012) in patients with mild to moderate Parkinson's disease. Regardless of whether this oscillatory condition will be replicable in 'ON-levodopa' controls, it still remains possible that the observed spectral effects reflect a direct impact of levodopa on the neurovascular coupling of the sensorimotor network regions. In the physiological case, this seems not likely as we did not observe similar frequency-selective spectral effects in other regions and networks. In the pathological case, the possible change in the neurovascular coupling may be facilitated by the blood-brain barrier hyperpermeability of the most affected regions, as suggested by a recent autoradiographic study comparing the levodopainduced changes in the regional cerebral blood flow (i.e. the major neurophysical component of the blood oxygen leveldependent signal) with the brain metabolism in the motor network of a Parkinson's disease animal model (Ohlin et al., 2012) . Along these directions, we also noticed that in some regions of interest of the basal ganglia, and particularly in thalamus and the caudate, levodopa increased the 'participation' to the sensorimotor network above the normative levels observed in the healthy control group, suggesting how this levodopa-induced up-regulation of the sensorimotor network functional connectivity, if related to the pathological state, could be somewhat facilitated in the basal ganglia (Ohlin et al., 2012) .
In our study, we did not monitor the tremor during scans, and therefore we cannot rule out the possibility that levodopa-induced tremor reduction could be a causative influence of the characteristic oscillations in the motor network. However, although tremor monitoring is theoretically auspicious, it should be considered that previous studies (Timmermann et al., 2003; Pollok et al., 2009 Pollok et al., , 2012 have demonstrated the presence of tremor-related oscillatory activity when the tremor was maximal, particularly after medication withdrawal. By contrast, under our experimental conditions, an increase in the oscillations was observed when the tremor was reduced by levodopa. Moreover, it should be taken into account that the additional spectral frequency peak associated with the sensorimotor network was detected in drug-naïve patients with Parkinson's disease treated with levodopa, which corresponded to the low-tremor condition, and not in the untreated drug-naïve patients with Parkinson's disease that corresponded to the high-tremor condition. Therefore, we believe that the presence or absence of tremor did not actually contribute to our findings. On the other hand, because controls were not exposed to levodopa, it remains conceivable that the described effects pertain to levodopa as an agent influencing the sensorimotor network functional connectivity per se rather than restoring striatal dopamine tones.
In conclusion, our findings demonstrate that levodopa increases functional connectivity of the sensorimotor network of drug-naïve patients with Parkinson's disease selectively in the supplementary motor area, where these signals are abnormally reduced compared with untreated healthy volunteers, and preferentially at the border of the pre-supplementary motor area, a cortical region specialized (and fundamental) for motor control. Moreover, we show that levodopa treatment confers to the sensorimotor network of drug-naïve patients with Parkinson's disease a more composite frequency spectrum compared with other resting-state networks, by stimulating a higher-frequency rhythm, not visible in untreated healthy volunteers. The presence of multiple low-frequency rhythms (not all equally modulated by the levodopa treatment) would support the hypothesis that multiple oscillating systems may contribute to restoring the resting-state functional connectivity of the sensorimotor network in levodopa-treated drug-naïve patients with Parkinson's disease. We hypothesize that this mechanism may be involved in the therapeutic effect of levodopa in patients with Parkinson's disease. 
